This demonstrates the potential of KLRK1/NKG2DLs as promising therapeutic targets for more effective antitumor treatment.[10] However, currently there is still relatively few studies have been conducted on KLRK1 and its ligands in HNSCC. Here, KLRK1 is linked to head and neck squamous cell carcinoma.